Authors
Loading...
Randomized trial identifies hub lncRNAs as potential prognostic indicators in gastric cancer subtypes, suggesting new pathways for treatment.
Goftari et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: